At long last, Eli Lilly has found success in its decades-long effort to develop a treatment for Alzheimer’s disease. The company announced Wednesday morning that its experimental drug, donanemab, sl… [+582 chars]Read More
Lillys Alzheimers drug donanemab succeeds in PhIII trial Endpoints News Endpoints News
